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Abstract
Background: Identifying which taxa are targeted by immunoglobulins can uncover important host-microbe
interactions. Immunoglobulin binding of commensal taxa can be assayed by sorting bound bacteria from samples
and using amplicon sequencing to determine their taxonomy, a technique most widely applied to study
Immunoglobulin A (IgA-Seq). Previous experiments have scored taxon binding in IgA-Seq datasets by comparing
abundances in the IgA bound and unbound sorted fractions. However, as these are relative abundances, such
scores are influenced by the levels of the other taxa present and represent an abstract combination of these effects.
Diversity in the practical approaches of prior studies also warrants benchmarking of the individual stages involved.
Here, we provide a detailed description of the design strategy for an optimised IgA-Seq protocol. Combined with a
novel scoring method for IgA-Seq datasets that accounts for the aforementioned effects, this platform enables
accurate identification and quantification of commensal gut microbiota targeted by host immunoglobulins.
Results: Using germ-free and Rag1−/− mice as negative controls, and a strain-specific IgA antibody as a positive
control, we determine optimal reagents and fluorescence-activated cell sorting (FACS) parameters for IgA-Seq.
Using simulated IgA-Seq data, we show that existing IgA-Seq scoring methods are influenced by pre-sort relative
abundances. This has consequences for the interpretation of case-control studies where there are inherent
differences in microbiota composition between groups. We show that these effects can be addressed using a novel
scoring approach based on posterior probabilities. Finally, we demonstrate the utility of both the IgA-Seq protocol
and probability-based scores by examining both novel and published data from in vivo disease models.
Conclusions: We provide a detailed IgA-Seq protocol to accurately isolate IgA-bound taxa from intestinal samples.
Using simulated and experimental data, we demonstrate novel probability-based scores that adjust for the
compositional nature of relative abundance data to accurately quantify taxon-level IgA binding. All scoring
approaches are made available in the IgAScores R package. These methods should improve the generation and
interpretation of IgA-Seq datasets and could be applied to study other immunoglobulins and sample types.
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Background
The immunoglobulin isotype A (IgA) is secreted by
plasma cells at mucosal barrier sites such as the gastro-
intestinal (GI) tract, which is also host to the densest
community of commensal bacteria in the human body
[1, 2]. Intestinal homeostasis requires tolerance to the
microbiota but a robust defence against pathogens, and
growing evidence suggests that IgA binding is both
taxon-dependent and context-specific. IgA in the mucus
layer forms a protective barrier between the epithelium
and the luminal microbiota [3–5]. Some commensal
bacteria have adapted to this specialized niche to pro-
mote homeostasis. Bacteroides fragilis produces a surface
polysaccharide that promotes IgA binding and facilitates
mucus layer colonization [6] and the mucin-degrader
Akkermansia muciniphila induces host IgA and IgG re-
sponses [7]. Other studies have suggested that low-
affinity IgA contributes to microbiota maintenance,
whilst high-affinity IgA acts on pathogens to promote
clearance and inhibit virulence [8–15]. Pathobionts are
members of the microbiota that are typically harmless
under homeostatic conditions but can drive disease
given certain environmental stimuli [16]. IgA binding of
taxa might also reflect such pathogenic potential and
IgA bound gut bacteria have been implicated in inflam-
matory disease [17–20]. Accurate identification of com-
mensal microbiota bound by IgA can therefore offer
important insights into the mechanisms underlying host
microbial mutualism and its dysregulation in disease.
Microbiota-wide profiling of IgA bound taxa can be
achieved using IgA-Seq. Anti-IgA antibodies are used to
stain a complex gut microbiota, then bound and un-
bound bacteria are separated by fluorescence-activated
cell sorting (FACS) or magnetic-activated cell sorting
(MACS) and identified by 16S rRNA gene sequencing
[17, 18]. We refer to the sorted IgA bound bacteria as
the IgA+ fraction, the sorted unbound bacteria as the
IgA− fraction and the sample before sorting as the pre-
sort sample. IgA-Seq has been used to uncover antibody
targeting of taxa by both T cell-dependent and T cell-
independent pathways [7, 10, 12, 21, 22], as well as dif-
ferential binding of taxa during disease. IgA-Seq was first
described by Palm et al. to identify taxa differentially
bound by IgA in inflammatory bowel disease (IBD) pa-
tients [17] and was adapted by Kau et al. to identify in-
creased binding of Enterobacteriaceae by IgA in
malnourished infants [18]. Variations of these protocols
have since been applied to study IgA binding in other
disease states, employing a range of IgA-Seq protocols
utilising different reagents, sort modalities and configu-
rations [19, 20]. Some of these parameters have been
validated individually in prior studies but there has yet
to be a comprehensive description of how to design and
benchmark an optimal IgA-Seq protocol.
More importantly, there has yet to be a formal consid-
eration of the analytical approaches used to score taxon
binding in IgA-Seq datasets. IgA-Seq does not quantify
the affinity of IgA antibodies directly, but rather provides
a measure of overall IgA binding. The likelihood of bac-
teria within a given taxon being bound by IgA will be in-
fluenced by a combination of the affinities of the IgA
pool for the taxon, the spatial distribution of those bac-
teria and the expression of relevant epitopes by the
taxon. Additionally, the IgA+ abundance does not solely
represent this likelihood of taxon binding. It is also a
function of the number of bacteria present: a taxon
highly targeted by host IgA could make up a low propor-
tion of the IgA+ fraction if only a few bacteria are
present and vice versa. The principal aim of IgA-Seq is
not to solely identify which taxa are most bound by IgA
but rather to identify those taxa with a higher likelihood
of binding relative to other bacteria. As a result, indices
that account for the initial quantities of bacterial taxa
must be applied to quantify IgA-Seq data.
In IgA-Seq studies to date, IgA binding has largely
been scored using indices as described by either Palm
et al. or Kau et al. (referred to here as the Palm and Kau
indices for clarity) [17, 18]. These scores compare the
abundance of a taxon in the IgA+ fraction to its abun-
dance in the IgA− fraction. This accounts for the overall
pre-sort quantities of taxa on the assumption that, as
both fractions are drawn from the same starting pool of
bacteria, the IgA+ and IgA− abundances are representa-
tive of the proportion of a taxon’s bacteria bound by
IgA. However, these scores are influenced by an add-
itional confounder—that these are relative abundances.
As a result, an increase in one taxon will inherently re-
duce the percentage contribution of others. Thus, the
IgA+ and IgA− abundances of a given taxon are also in-
fluenced by the starting abundances and IgA binding of
all other taxa. Scores like the Kau and Palm indices cor-
relate with taxon-level IgA binding but the necessity to
use relative abundances in IgA-Seq experiments ab-
stracts their interpretation. We will show that, without
careful consideration of these effects, it is possible to
misinterpret results observed using these metrics.
Here, we aim to address these methodological and
analytical limitations to improve the accessibility, quality
and quantitative interpretation of IgA-Seq experiments.
Using germ-free and immune-deficient mice as negative
controls and a strain-specific IgA antibody for positive
controls, we describe the methods that can be used to
validate the quality of each stage of an IgA-Seq experi-
ment and derive an optimised IgA-Seq protocol. In lieu
of a gold standard for benchmarking IgA binding scores,
we develop a platform for simulating an IgA-Seq experi-
ment where the underlying relative IgA binding levels
between taxa are known. Using this, we show that
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existing indices used to score taxon-level IgA binding
are influenced by relative abundances, which needs to be
taken into account when drawing conclusions. We
present novel probability-based scores that circumvent
this by providing direct quantification of the proportion
of bacteria belonging to a given taxon that are bound by
IgA. Finally, we demonstrate the utility of the protocol
and novel probability scores by applying them to study
IgA binding in mouse models of colitis and malnourish-
ment. These methods facilitate generation of high-
quality IgA-Seq data and direct quantification of relative
immunoglobulin binding between taxa.
Results
Quality control standards for bacterial flow cytometry
and IgA staining
We first determined the optimal gating strategy for iso-
lating bacteria from faecal and colonic samples by FACS.
The BD LSRFortessa X20 and FACSAria III flow cyt-
ometers were selected based on an identical configur-
ation with 405, 488, 633 and an additional 561 nm laser,
which eliminated PE-FITC spill over and increased PE
sensitivity. Whereas eukaryotic cells have diameters ran-
ging from 10 to 100 μm, bacteria generally range from
0.3–5 μm, though some can vary by two orders of mag-
nitude and have variable width to height ratios. In stock
configurations, both these cytometers use a sensitive
photomultiplier tube (PMT) to detect side scatter (SSC),
and therefore a minimum SSC threshold was used to
fully capture a wide range of particle sizes.
Bacteria must then be distinguished from small debris
particles in the buffers and the sample itself, particularly
in faecal samples which contain substantial autofluores-
cent debris. For this, nucleic acid dyes have been recom-
mended in flow cytometry applications for diverse hosts
and environments [23–28], and help ensure collection of
adequate DNA for IgA-Seq studies [12, 18–20, 29–31].
It must be noted that nucleic acid staining may be variable
amongst diverse bacteria due to differences in cell perme-
ability and transport mechanisms, the size and number of
copies of genomic DNA and/or asymmetric division.
Studies comparing various DNA dyes have found that the
cell-permeable SYBR Green I effectively stained phylogen-
etically distant bacterial strains, was the most sensitive
and bound specifically to DNA; in contrast to DAPI which
bound non-bacterial particles [25, 26]. This reagent had
also been used successfully in previous studies of im-
munoglobulin coating [30, 31], and was thus selected for
our IgA-Seq protocol. To accommodate bacteria that
stained weakly with SYBR, we utilised a broad gating strat-
egy to capture as much of this heterogeneity as possible
(Fig. S1A). Our SYBR+ gating strategy identified bacteria
in samples from specific pathogen-free (SPF) mice but did
not stain filter-sterilized FACS buffer or stool from germ-
free (GF) mice (Fig. S1A). This approach defined SYBR+
gating parameters that were specific for microbes whilst
minimising contaminating debris (Fig. S1A).
Next, we sought to validate the specificity of the PE-
conjugated rat anti-mouse IgA (mA-6E1) antibody that
would be used in downstream IgA-Seq experiments. We
used IgA-deficient mice as negative controls and a bac-
terial strain-specific IgA antibody as a positive control.
SPF Rag1−/− mice have a complex microbiota but lack T
cells and mature B cells responsible for the production
of IgA. Essentially, no bacteria were stained by the PE
anti-mouse IgA antibody in samples from Rag1−/− mice
compared to roughly 4% of the microbiota in wild-type
SPF mice (Fig. S1B). To further confirm the specificity of
the IgA antibody, we replicated the approach of Kau
et al. [18], using an in vitro system with an artificial 2-
member bacterial community in which only one strain
should be stained by PE anti-mouse IgA. Bacteroides
thetaiotaomicron (B. theta) strain VPI-5482 was coated
with mouse IgA antibody clone 225.4, which is specific
to the capsular polysaccharide of strain VPI-5482 and no
other B. theta isolates [32]. Escherichia coli was coated
with a mouse IgG antibody as a control and mixed with
the labelled B. theta prior to staining with the PE anti-
mouse IgA antibody. Flow cytometry revealed that a
proportion equivalent to the expected B. theta popula-
tion was stained by the PE anti-mouse IgA antibody
(Fig. S1C), confirming the specificity of the antibody to
be used in downstream IgA-Seq experiments. The gating
strategy used for the IgA-Seq protocol (Fig. 1a) was vali-
dated using these SYBR and IgA staining controls.
A benchmarked protocol for IgA-Seq
The goal of IgA-Seq is to isolate bacterial populations
coated by endogenous host IgA and to identify them by
16S rRNA gene sequencing. To this end, it is critical to
identify FACS parameters that maximise the integrity
and purity of sorted samples. Using B. theta as a model
commensal anaerobe, a culture-grown suspension of B.
theta VPI-5482 was once again labelled with strain-
specific IgA and PE anti-mouse IgA, and 100 cells were
sorted as an array onto an agar plate to determine viable
colony-forming units (CFU). The default cytometer set-
tings for 100 and 85 μm nozzles were tested, in addition
to a custom 30 psi configuration for the 85 μm. Intact
bacterial recovery decreased with smaller nozzles sizes
and higher pressures, and viability was enhanced by sort-
ing at the lower 30 psi pressure on the 85 μm nozzle
(Fig. 1b). Only 20% of bacteria could be recovered with
the 70 μm nozzle (Fig. 1b), which was discontinued from
further testing.
To test the sort fidelity of the fractions produced by
each of the configurations, we sorted IgA+ and IgA− bac-
terial populations from SPF mouse stool (Fig. 1a). These
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fractions were then analysed using the same parameters
to determine the percentage of bacteria that were
retained within defined sort gates. All three FACS con-
figurations enabled > 90% sort purity for both IgA+ and
IgA− fractions (Fig. 1c). This is in contrast to magnetic-
activated cell separation (MACS), an alternative sorting
modality which performed poorly with purities of 37.1–
42.9% for the IgA+ fraction (Fig. 1d, e). The FACS con-
figuration utilising the 100 μm nozzle produced the
highest sort purities in both IgA+ and IgA− fractions,
Fig. 1 Benchmarking a protocol to isolate IgA+ and IgA− faecal bacteria by fluorescence activated cell sorting. a IgA-Seq gating strategy. Faecal
bacteria from SPF C57BL/6 mice stained with anti-mouse IgA (PE). Gating on a population based on FSC and SSC characteristics, followed by
discrimination of SYBR+ (FITC) bacteria from autofluorescent (PerCP Cy5.5) debris. IgA+ and IgA− populations were sorted from SYBR+ cells. b
Viability of B. theta VPI-5482 (Bt) collected by various nozzle sizes (μm) and sheath pressures (psi) on the FACSAria III. Culture-grown Bt was
stained with mouse anti-Bt IgA (clone 255.4) and rat anti-mouse IgA (PE, clone mA-6E1). One hundred cells were plated in single cell precision
mode onto BHIS agar plates for enumeration of colony forming units (CFU). c IgA+ and IgA− fractions were collected from SPF C57BL/6J mice (n
= 3). Left: percentage of IgA+ faecal bacteria detected in each collected fraction for a range of nozzle and pressure configurations. Right: sort
purities for these configurations defined by the percentage of events that remained in the designated sort gates. Lines represent means with
SEM. dA portion of the IgA-stained faecal suspensions from Fig. 2a were also separated into IgA+ and IgA− fractions by magnetic activated cell
separation (MACS) as a comparison. PE IgA-stained samples were incubated with anti-PE microbeads and fractions collected by LS column
separation. Representative flow cytometry plots of the starting material in SPF stool and the IgA+ and IgA− fraction isolated by FACS and MACS. e
MACS purity of collected fractions as determined by flow cytometry, technical triplicates from the same stool suspension
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followed by the 85 μm nozzle at 30 psi (Fig. 1c). Practic-
ally, the low pressure required for the 100 μm nozzle re-
duces the flow rate and throughput by ~ 70%. Given that
a minimum of 400,000 cells are required per fraction for
downstream sequencing applications, the 85 μm with 30
psi configuration is vastly more time effective whilst
maintaining high viability and sort purities. We also
found this configuration allowed for sensitive sort con-
trol that, if desired, allows for finer grain collection of
IgA+ subpopulations for instance IgAbright and IgAdim
fractions (Fig. S2). This configuration was selected for
downstream IgA-Seq.
As a final test of the precision of our sorting approach,
we devised an experiment to specifically isolate an IgA+
strain from a complex stool microbiota. We once again
took advantage of our ability to coat B. theta VPI-5482
with mouse IgA in a strain-specific manner, which we
stained separately before spiking into an unstained faecal
suspension prepared from SPF wild-type C57BL/6 mice
(Fig. 2a). Though some members of the faecal micro-
biota are coated by endogenous host IgA, because the
faecal suspension was not stained, only the PE anti-
mouse IgA stained B. theta VPI-5482 culture should be
isolated with this approach. B. theta VPI-5482 was not
found in the SPF stool without spike-in and comprised
roughly 12.5% of the whole community in the spiked
stool mixture, and high sort purities were achieved for
both the IgA+ (97.4–99.4%) and IgA− fractions (97.3–
100%) across three replicate sorts (Fig. 2b). 16S rRNA
gene sequencing was performed on the complex stool
community prior to the addition of B. theta VPI-5482,
and in addition to the IgA+ fractions after three sorts
from the same spiked sample. Genomic DNA from B.
theta was included as a positive control. As a
Fig. 2 Testing IgA-Seq specificity in a complex faecal microbial community. Culture-grown Bt VPI-5482 was stained with mouse anti-Bt VPI-4582
IgA (clone 255.4) and rat anti-mouse IgA (PE, clone mA-6E1), then spiked into an unstained faecal suspension prepared from SPF C57BL/6J mice
with a complex microbiota. a Experimental design and sort setup, gated on SYBR+ cells. b Sorts repeated on the same Bt-stool suspension to
generate technical triplicates. Left: percentage of IgA+ bacteria in the pre-sorted sample, IgA+ and IgA− fractions. Right: purity check on the
collected fractions. Lines represent means with SEM. c Taxa abundances based on 16S rRNA gene sequencing of a complex stool microbiome
(triplicate sequencing replications stool 1–3), triplicate sorted IgA+ fractions (sort 1–3) and Bt genomic DNA (Bt gDNA). Top 10 genera are shown.
d Relative abundance of Bt VPI-5482 (ASV399) in sorted samples
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contamination check, sheath fluid and an extraction
blank (no sample added) were also included as controls,
but these contained undetectable quantities of DNA and
did not produce a viable library. Whilst endogenous
Bacteroides species are present in the faecal microbiota
(Fig. 2c), amplicon sequence variant (ASV) level analysis
confirmed that strain VPI-4582 is absent from C57BL/6
mice (Fig. 2d). The IgA+ fractions were comprised al-
most entirely of B. theta VPI-5482 (ASV399, 98.4–
99.6%; Fig. 2c, d) and lacked any additional unstained
taxa observed in the complex community. This demon-
strates that our optimised protocol can sort IgA bound
bacteria from a complex gut microbiome with high
accuracy.
Pre-sort differences in taxonomic composition and the
relative nature of abundances influences existing IgA
binding scores
Once a sample has been sorted, amplicon-based sequen-
cing of extracted DNA from the sort fractions is used to
determine the relative abundances of the taxa within
them. As discussed previously (see “Background”), the
abundance of a taxon in the IgA+ fraction is a function
of both its likelihood of IgA binding and its overall
abundance in the pre-sort community. As we are princi-
pally interested in the former, we must use scoring met-
rics to quantify the relative IgA binding of taxa whilst
taking their pre-sort abundances into account. To date,
this has principally been achieved using indices that
compare taxon abundances in the IgA+ and IgA− frac-
tions and two such indices have been described—the
Palm and Kau indices (see “Methods”). Using a toy ex-
ample where two samples have identical IgA binding af-
finities for two species but differ in their starting
abundances, we can see that these scores are still influ-
enced by pre-sort abundances and produce different af-
finity scores for each sample (Fig. 3a). This is because
these scores do not account for the fact that abundances
are relative measures and thus the starting abundance
and IgA binding of all other taxa will also influence the
observed abundance of a given taxon in the sorted
fractions.
If we instead consider the IgA+ relative abundance as
the probability of a taxon being within the IgA+ fraction,
it is possible to apply Bayes’ theorem to derive a poster-
ior probability of IgA binding for each taxon, i.e. the
probability that a given bacterium will be bound to IgA
given that it belongs to a given taxon (see “Methods” for
a more detailed discussion). In our example, this poster-
ior probability is not influenced by the effect of pre-sort
taxonomic composition on relative abundances and pro-
vides a direct quantification of the likelihood of IgA
binding for each taxon (Fig. 3a). It is also possible to
apply the same approach to the IgA− fraction and
estimate the probability a bacterium will be in the IgA−
gate given that is belongs to a given taxon. Here, we de-
scribe two scoring methods based on these posterior
probabilities: (1) the IgA+ probability—direct use of the
IgA+ fraction probability; (2) the probability ratio—a
composite score derived from the ratio of the IgA+ frac-
tion probability to the IgA− fraction probability (see
“Methods”).
Probability-based scores accurately recapitulate relative
IgA binding in simulated data
As the true level of IgA binding to each bacterial taxon
cannot be measured directly in vivo, we created a plat-
form to simulate an IgA-Seq experiment in silico to
benchmark scoring methods. This allowed IgA-Seq data
to be generated with pre-defined relative levels of IgA
binding between species. In each simulation, we main-
tain the relative level of IgA binding for each species
across all samples and only change the pre-sort abun-
dances of species. This allows us to determine how ro-
bust scoring methods are to these effects. A perfect
scoring method should produce identical IgA binding
scores for each species across all samples, with a relative
ranking of IgA binding between species that matches the
pre-defined levels.
Ten species were simulated, each having a unique nor-
mal distribution of IgA binding. IgA binding was repre-
sented by an arbitrary value that just represents the
relative levels of binding between taxa (Fig. 3b). Thirty
samples were generated each containing 100,000 bac-
teria. The bacteria were assigned to each of the ten spe-
cies randomly to produce different log distributed
starting abundances for each sample (Fig. 3c). Each bac-
terium in each sample was then assigned an IgA binding
value by sampling from the distribution of its species.
Bacteria whose binding values were above four were
considered IgA+ and those below two in the IgA− frac-
tion. These thresholds were chosen based on the overall
distribution of IgA values to mimic the extremes se-
lected in a typical IgA-Seq experiment (Fig. 3b). The
number of bacteria in each sample’s IgA+ and IgA− frac-
tion was used to determine the size of the fractions and
the species counts were converted to taxonomic relative
abundances (Fig. 3c). These values were in turn used to
derive the various IgA binding scores.
Samples had different IgA+ and IgA− fraction sizes, de-
fined as the percentage of total bacteria within the frac-
tion, due to their different initial taxonomic
compositions and the differing IgA binding of the ten
species (Fig. 3d). Given that each taxon’s IgA binding
was constant across samples, we would expect there to
be no variation across samples if an IgA binding score
properly adjusts for the differences in sample compos-
ition. Comparing the consistency of scoring methods
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Fig. 3 The influence of pre-sort abundances on existing IgA-Seq scores can be overcome using probability-based approaches. a A toy example
where two samples have two species with the same IgA binding profiles but different starting abundances. b The distribution of arbitrary IgA
binding values used for the ten species in the IgA-Seq simulations, dashed lines indicate the IgA+ and IgA− fraction thresholds. Species coloured
as in (c). c The species abundances in the pre-sorted, IgA+ and IgA− samples for the 30 samples simulated. d The size of the IgA+ and IgA−
fractions in the simulated samples as a percentage of their total bacteria. e Comparison of variance in IgA binding estimates across samples using
each scoring approach. Coefficient of variance was calculated for each species individually. **p < 0.01, ****p < 0.0001 in Mann-Whitney tests after
FDR correction. Boxes represent the median and interquartile range (IQR) and the whiskers the largest and smallest values within one and half
IQR of the upper and lower IQR limits. f Pearson and Spearman correlations between the true mean IgA binding scores used to simulate data
and the scores estimated by each of the different indices
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across samples, the IgA+ probability had a significantly
lower coefficient of variation than the Palm index and
the probability ratio had significantly lower variation
than all other scores. The probability-based methods
were more consistent than the Palm and Kau indices,
and thus less influenced by the differences in pre-sort
taxonomic composition between samples (Fig. 3e).
When considering the relative rankings of the species,
all four scoring methods were significantly correlated
with the true IgA binding affinities and ranked species in
the correct order of IgA binding (Fig. 3f). However, the
Palm and Kau indices had a lower correlation than ei-
ther of the probability-based methods due to the larger
variation between samples. Comparing the results of
Pearson and Spearman correlations, it is apparent that
the Kau and probability ratio scores produce a more lin-
ear distribution than the other two methods. This is due
to their consideration of both the IgA+ and IgA− frac-
tions, which is not in the case in the IgA+ probability,
and taking the log to centre the score, which is not the
case in the Palm index or IgA+ probability. Overall in
this initial simulation, probability-based methods proved
robust to the influences of pre-sort taxon levels on post-
sort relative abundances, which introduced variability to
the Palm and Kau indices. The probability ratio almost
perfectly recapitulated the relative relationships of the
true IgA binding values.
Probability-based methods overcome biases effecting the
interpretation of between group comparisons
The Kau and Palm indices showed variation in scores
due to pre-sort differences in taxonomic composition.
This could be particularly problematic when comparing
IgA binding between groups that have inherent and con-
sistent differences in microbiome composition. This is
likely, as a key use-case for IgA-Seq is to determine if
previously established microbiome differences between
groups, such as healthy controls and disease patients, are
being driven by differential targeting of the IgA pool.
To determine the effects of pre-sort compositional dif-
ferences on inter-group comparisons, we repeated the
simulation but divided samples into a case and control
group. The simulation was run with 30 samples per
group each containing ten species with the same under-
lying IgA affinities as before (Fig. 3b). Random initial
abundances were then generated as previously but add-
itional Species 10 (with a moderate IgA affinity value)
was introduced to the 30 case samples—simulating out-
growth of one specific taxon in a disease. In this simula-
tion, as before, an optimal scoring approach will not
detect any differences between the cases and controls
whose species share the same IgA binding and only dif-
fer in their pre-sort composition.
As expected, Species 10 constituted a larger percent-
age of the relative abundances in both the IgA+ and
IgA− fractions of the cases compared to the controls
(Fig. 4a). This led to a significantly higher IgA− fraction
size in the control group when compared to cases but
no difference in the IgA+ fraction sizes (Fig. 4b). Com-
paring the overall distribution of scores, there was
greater variability across samples in the Kau index than
the probability ratio, and Species 10 IgA binding esti-
mates were higher in cases using the Kau index (Fig. 4c).
When testing differences between the simulated case
and control groups, the Kau index inferred significant
differences in the IgA binding of both Species 10 and
Species 6 where there should be none (Fig. 4d). This is
an artefact of measuring relative abundances. In the sim-
ulated disease cases, there was an increased abundance
of Species 10 in the IgA+ fraction. This reduces the rela-
tive contribution of Species 6 (the highest affinity taxa
that would otherwise constitute the majority of the IgA+
fraction) and alters the ratio when calculating the Kau
score. No significant differences were observed using the
Palm index but this only resolved the highly bound Spe-
cies 6, which displayed increased variance in the controls
(Fig. S3). The probability ratio resolved both high and
low IgA binding of taxa and was more resistant to the
influence of the pre-sort abundances, maintaining simi-
lar estimates between cases and controls (Fig. 4d).
IgA-Seq in a mouse model of colitis produces different
outcomes across scoring methods
To demonstrate the utility of our benchmarked IgA-Seq
protocol, we applied it to study commensal IgA binding
in a mouse model of colitis. Helicobacter hepaticus (Hh)
can inhabit the murine intestinal tract without harm but
can emerge as a pathogen when host immune responses
are dysregulated as a result of either genetic susceptibil-
ity or targeted immunomodulation [33]. Abrogation of
anti-inflammatory IL-10 signaling by administration of
an anti-IL10 receptor antibody (aIL10R) results in Hh-
driven colitis [34]. We recapitulated this model in a
gnotobiotic C57BL/6 mouse colony stably colonized
with a 12-member microbiota (MM12) that recapitulates
the taxonomic diversity of a more complex community
[35]. This provides a defined minimal microbiota to spe-
cifically interrogate IgA binding.
Control MM12 mice treated solely with weekly aIL10R
injections did not develop any pathology (Fig. 5a). In
contrast, MM12 mice that received aIL10R in conjunc-
tion with H. hepaticus (Hh+aIL10R) developed marked
inflammation and colitis after 14 days (Fig. 5a).
Lipocalin-2, released by activated neutrophils and a bio-
marker for inflammation [36], was also elevated in the
colon contents of Hh+aIL10Rmice but not control
aIL10R only mice, whose lipocalin-2 levels were similar
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to steady-state mice lacking aIL10R injection (Fig. 5b).
There was a significant increase in IgA-coating of co-
lonic bacteria from colitic mice (Fig. 5c, d). Colonic con-
tents from both control and colitis groups were
subjected to IgA-Seq to identify taxa targeted during
inflammation.
Taxa were profiled in the pre-sort samples and the
IgA+ and IgA− fractions using 16S rRNA gene
Fig. 4 The probability ratio overcomes pre-sort abundance biases when carrying out between-group comparisons. a Simulations were carried out
as in Fig. 3 with an additional 30 samples that were initiated with an exaggerated abundance of Species 10 (cases). This plot shows the species
abundances in these case and control samples’ pre-sort, IgA+ and IgA− fractions using the thresholds as in Fig. 3b. b Differences in the IgA+ and
IgA− fraction sizes as a percentage of total bacteria between cases and controls. P value shown from Mann-Whitney tests. c Heatmaps showing
the scores estimated by the Kau and probability ratios across all samples. d Comparison of IgA binding scores for the ten species in cases and
controls when using either the Kau score or the probability ratio. Significant differences are highlighted with * (FDR adjusted Mann-Whitney p <
0.05) and species are ordered by true IgA binding value. In all boxplots the boxes represent the median and interquartile range and the whiskers
the largest and smallest values within one and half IQR of the upper and lower IQR limits. In (d), points outside this range are shown
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Fig. 5 IgA-Seq in a mouse model of colitis with a defined 12-member microbiota. MM12 mice were administered weekly injections of anti-IL10R
(day 0, 7). Controls received anti-1L10R alone (aIL10R, n = 4), and the colitis group were additionally infected with H. hepaticus at the start of the
experiment (Hh+aIL10R, n = 4). a Experimental design and representative colon histology with haematoxylin and eosin staining. b Mouse
lipocalin-2 ELISA as a measure of colonic inflammation. Lines at means and SEM. **p < 0.01 unpaired Mann-Whitney test, ns non-significant. SS
represents steady state mice with no aIL10R exposure. c Representative flow cytometry plots of the percentage of colonic MM12 bacteria coated
by IgA. d Percentage of bacteria coated by host IgA and subjected to IgA-Seq. P values represent Mann-Whitney tests. e Relative abundance
plots showing the MM12 species in each sample. Each row represents an individual animal. f Non-metric multi-dimensional scaling of pre-sort,
IgA+ and IgA− fractions from Bray-Curtis distances. g Left: means and 95% confidence intervals of IgA binding scores significantly different
between groups. Significance determined by complete permutation of group labels where, exact permuted p < 0.1). Right: Mean difference of
scores between groups (colitic -control). Mean is normalised by its standard deviation for comparability between scoring methods (using the
strictly standardised mean difference SSMD). h Left: boxplots of A. muciniphila relative abundance. Centre: boxplots of IgA+ fraction size. Right:
boxplots of adjustment for the difference in fraction size (abundance in the IgA+ fraction size multiplied by A. muciniphila abundance). In the
boxplots in (d) and (h), boxes represent the median and IQR and the whiskers the largest and smallest values within one and half IQR of the
upper and lower IQR limits
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sequencing. Analyses were carried out at the level of
species summarised ASVs. Using the V4 16S rRNA gene
region, we were able to distinguish almost all members
of the MM12 and Hh either by species level assignment
or sole membership of a genus (Table S1). The excep-
tion was two closely related Clostridium species that
were both assigned to Clostridium XlVa. A blank se-
quencing control was used to identify potential contami-
nants introduced at the DNA extraction and library
preparation stage. Given that we used mice with a de-
fined microbiota, we were also able to determine the
presence of contaminants introduced elsewhere. After
removing taxa observed in the blank control, several un-
expected (non-MM12 or Hh) species remained (Fig.
S4A). The majority of these were at a lower abundance
than the expected species across all samples. These were
removed from later analyses using an abundance thresh-
old chosen to remove rare taxa whilst retaining the ma-
jority of total observations (Fig. S4B). It is of note that
contaminant taxa were far more predominant in the
sorted IgA+ and IgA− fractions. This may be due to the
lower biomass in these samples but could also be due to
species being introduced during sorting or library prep-
aration. These were accounted for by additional screen-
ing to only retain species observed in the pre-sort
sample for each mouse, which led to no unexpected taxa
being observed in any sample (Fig. S4C). Thus, we rec-
ommend using abundance thresholding followed by val-
idation against pre-sort samples to filter taxa prior to
scoring in IgA-Seq analyses.
After quality control, Hh was detected in the whole
and IgA+ fractions of all four Hh+aIL10R mice and sam-
ples clustered clearly by both experimental condition
and sort fraction (Fig. 5e, f). Hh was also detected in the
pre-sort sample in one of the aIL10R only mice, but as
this was not detected in either the IgA+ or IgA- frac-
tions, it ultimately did not influence the IgA binding
scores for this mouse. We compared the different IgA
binding scores across all mice, focusing on the methods
that included both the IgA− and IgA+ fractions. All
methods broadly ranked species IgA binding in the same
order and there was a significant positive correlation be-
tween all scores (Fig. S5A). The Kau index and probabil-
ity ratio shared the strongest correlation, with the main
difference between the two being a more even distribu-
tion of values within the probability ratio than in the
Kau index, which contained isolated peaks of scores
where taxa were predominantly observed in the IgA+ or
IgA− fraction (Fig. S5A).
When comparing species IgA binding scores between
groups, the method used had important and distinct ef-
fects on the interpretation of the results. All methods
identified significant differences in IgA binding of Clos-
tridium between the Hh+aIL10R and aIL10R only
treatments (Fig. 5g, Fig. S5B). This was the largest effect
observed and was clearly detected by all three methods
in the same direction with an increased IgA binding of
Clostridium in colitic mice. Some taxa, such as Entero-
coccus, were only observed in the IgA+ and/or IgA− frac-
tions in the colitic mice. It was therefore not possible to
compare their binding relative to the control mice. This
highlights the need to additionally observe presence/ab-
sence patterns of taxa in the fractions alongside using
quantitative scoring methods.
The Kau index and probability ratio additionally de-
tected a significant difference in IgA binding to A. muci-
niphila between the groups. However, the Kau and Palm
scores were lower for A. muciniphila in colitic mice,
whereas the probability ratio was higher (Fig. 5g). This
discrepancy results from the large contribution of Hh to
the relative abundances in the IgA+ fraction of the colitis
group. This inherently reduced the observed relative
abundance of A. muciniphila in this fraction even in the
absence of a change in the absolute levels bound to IgA.
This is less pronounced in the IgA− fraction (where less
Hh is observed) and thus the overall IgA+/IgA− ratio of
A. muciniphila was reduced (Fig. 5g). However, even
though A. muciniphila accounts for a reduced percent-
age of the IgA+ fraction, the total IgA+ fraction is much
larger in the colitic mice (Fig. 5h). A smaller percentage
of this much larger total IgA+ fraction actually repre-
sents a larger total amount of A. muciniphila bound to
IgA in the colitic group (Fig. 5h). Thus the probability
ratio, which accounts for the fraction sizes, infers a posi-
tive rather than negative shift in IgA binding of A. muci-
niphila. This highlights the benefit of using probability-
based metrics that provide a direct estimate of the likeli-
hood of IgA binding for each taxon in comparison to
solely abundance-based indices, which might lead to a
conflicting interpretation without careful consideration
of what the scores represent.
The probability ratio increases power to detect
differences in IgA binding between conditions
As an additional test of the probability ratio, we applied
it to a published IgA-Seq dataset with extensive experi-
mental evidence to support differences in IgA binding
between conditions. Huus et al. used FACS-based IgA-
Seq to study bacterial binding of GI IgA in a mouse
model of nutrient restriction [20]. Mice on a conven-
tional (CON) or moderately malnourished diet (MAL)
were tracked from weaning to adulthood. Applying the
Kau index, they found that mice on a conventional diet
develop increased binding of Lactobacillus as they age
from three to seven weeks old, whereas malnourished
mice do not. They observed this effect to be consistent
across different sites in the GI tract and confirmed it
was driven by differential binding of IgA to Lactobacillus
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using an enzyme-linked immunosorbent assay (ELISA).
This provided an ideal dataset to test the robustness of
the probability ratio.
Huus et al. provided processed 16S rRNA gene sequen-
cing data generated from faecal samples used in their
study and the associated IgA+ and IgA− fraction sizes,
which had been recorded for a subset of the original data
[20]. This enabled the probability ratio to be calculated for
samples from four CON and MAL mice at each of the
three ages. The Kau score (used in the original study) was
also calculated as a comparator.
Comparing between diet and ages using the Kau index, we
identified five taxa with differential IgA binding (Fig. 6a).
Lactobacillus was the only taxon significantly different by the
interaction of age and diet and reflected the patterns
observed previously. Three taxa, Lactococcus and unclassified
Lachnospiraceae and Erysipelotrichaceae, displayed increased
IgA binding in MAL mice. All three of these taxa were ob-
served with the same association in the original analysis of
the dataset. We additionally observed a reduced IgA binding
of Roseburia in 3week-old MAL mice. This was not reported
in the Huus et al. analysis using the Kau index. However,
due to the smaller sample size available we explicitly targeted
our testing to between group effects and the prior analysis
did not.
Carrying out similar modelling using the probability
ratio to score IgA binding, we reproduced all of the as-
sociations identified using the Kau index with the excep-
tion of the unclassified Erysipelotrichaceae taxon, which
was no longer significantly different between groups
Fig. 6 Increased power when using the Probability Ratio to reanalyse data from Huus et al. 2020. a Boxplots showing the Kau index scores at
each age for all taxa that were significantly different by either diet or the interaction of age and diet in two-way ANOVAs (nominal p < 0.05).
Each plot shows which of diet and the diet:age interaction were significant and their p-values. Boxes represent the median and IQR and the
whiskers the largest and smallest values within one and half IQR of the upper and lower IQR limits. UC represents taxa that were unclassified
below the given taxonomy. b Plot as in (a) but for the probability ratio scores. c Left: Scatterplot of the p-values for all the comparisons that were
significant in either (a) or(b) showing the p value when using the Probability Ratio (y) or Kau Index (x). The red-line shows y = x, highlighting the
lower p values in the probability ratio tests. Right: Scatterplot as for p values but showing the effect size (difference in means between the two
diets) at each of the three ages for all of the significant comparisons in (a) and (b). Effect size is quantified as the strictly standardised mean
difference (MAL-CON). d Boxplots comparing the absolute coefficient of variation of each taxon’s score within each experimental group (for all
taxa detected in the Huus et al. dataset) when using either the Kau Index or probability ratio. Significance shown from Mann-Whitney U test
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(Fig. 6b). Across all of the other associations detected as
significant by either the Kau Index or probability ratio,
the probability ratio consistently produced lower p
values (Fig. 6c, left). This reflects an increased magni-
tude in the differences between the mean scores of the
MAL and CON groups in most comparisons when using
the probability ratio compared to the Kau index (Fig. 6c,
right). This can in part be attributed to a reduced vari-
ation in taxon scores within groups when using the
probability ratio (Fig. 6d), as was also observed in the
simulated data (Fig. 3e). This increased power is an add-
itional benefit of accounting for the size of the IgA+ and
IgA− fractions when scoring IgA-Seq data.
Discussion
The development of IgA-Seq has enabled powerful, un-
biased investigation of immune interactions between
host and commensal microbiota. As this technique gains
wider adoption, it is critical to benchmark experimental
and analytical approaches to ensure accurate quantifica-
tion and interpretation of IgA targeting. To this end, we
provide an optimised IgA-Seq protocol and novel scor-
ing approaches that facilitate accurate identification of
IgA-coated bacteria. We developed a simulation plat-
form that enabled the first formal testing of IgA-Seq
scores. This revealed that existing scoring approaches
are influenced by relative abundances and, without care-
ful consideration, can lead to the inference of alternate
IgA binding patterns solely as a result of pre-sort abun-
dance shifts. Instead, we have developed new
probability-based scoring methods that overcome these
limitations by directly quantifying the likelihood of a
taxon being bound by IgA. Importantly, as we have
showed in both simulated and in vivo datasets, these
probability-based scores provide increased power to de-
tect differences in IgA binding between groups and pro-
mote accurate interpretation of IgA targeting of taxa in
health and disease states.
Analysis of in silico and in vivo datasets revealed that
it is critical to properly account for the pre-sort taxo-
nomic composition of a sample given its effect on the
relative nature of post-sort fraction abundances when
comparing IgA targeting between case and control
groups. Scoring indices that neglect to do so can infer
artificial and/or conflicting shifts in IgA binding esti-
mates between experimental groups. Simulating consist-
ent group-wise shifts in pre-sort abundances resulted in
significant differences in taxon level binding estimates
when using the Kau index. It is not that the Kau scores
are incorrect, but rather that they represent an abstract
combination of both the IgA binding and abundance of
the taxon scored, and the IgA binding and abundance of
all other taxa in the sample. This inherently complicates
their interpretation. In contrast, the probability-based
scores adjust the taxonomic abundances by the number
of bacteria in IgA+ and IgA− fractions. This overcomes
the relative nature of quantification, which removes the
influence of other taxa, and allows for proper adjustment
for pre-sort composition. As a result, probability-based
scores provide a direct measure of the likelihood that a
bacterium is bound to IgA given that it belongs to a spe-
cific taxon. As shown with the increased binding of A.
muciniphila in the colitis model, this simplifies the inter-
pretation of between group changes in IgA binding
when using the probability ratio.
Aside from artefacts that arise in between-group com-
parisons, all scoring indices were correlated when con-
sidering global patterns across samples. This suggests
that taxa ranked as generally highly bound in previous
studies are unlikely to change if quantified using the
novel probability-based scores. However, we found that
the influence of pre-sort taxonomic composition meant
there was higher variability between samples when using
the Kau and Palm scores compared to the probability-
based methods. This increased variance reduces the
power to detect effects in experimental data and resulted
in a moderate increase in power when applying the
probability ratio to the Huus et al. data. Maximising
power by using probability-based metrics is particularly
desirable given the high investment of experimental time
required to generate IgA-Seq data, which can introduce
a practical limit on sample sizes.
Our work highlights the importance of selecting scores
based on the underlying biological question.
If the primary interest is to simply identify which taxa
have the most bacteria bound by IgA, then the IgA+
abundance of a taxon can be used directly. If the pur-
pose is to identify which taxa are being more/less prefer-
entially bound over other taxa, which is arguably more
relevant when studying IgA targeting, then probability-
based scores that account for the relative nature of taxo-
nomic abundances should be used (Fig. S6). To select
between using the IgA+ probability or probability ratio:
if the sole interest is to identify taxa most likely to bind
IgA then the IgA+ probability is sufficient and benefits
from its direct interpretability as a probability of IgA
binding (ranging from 0 to 1); otherwise, the probability
ratio provides a more generally applicable score that also
provides better resolution of relative binding between
taxa with lower IgA binding. For example, detecting the
loss of Lactobacillus binding in undernourished mice de-
tected in the Huus et al.’s study [20]. The probability ra-
tio additionally benefits from being centred on zero, so a
positive or negative score indicates if the majority of a
taxon’s bacteria fall into the IgA+ or IgA− fraction re-
spectively. Score choice might also be based on available
sequencing data. The IgA+ probability requires sequen-
cing of the IgA+ fraction and the pre-sort sample and
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the probability ratio requires sequencing of the IgA+ and
IgA− fraction. However, sequencing of both the IgA+
and IgA− fractions and the pre-sort sample has often
been applied in previous studies [17, 18]. As we have
shown here, this provides additional benefits in the de-
tection of contaminants introduced by sorting and over-
all compositional differences between experimental
groups.
We have also presented an optimised IgA-Seq protocol
that enables precise separation of IgA+ and IgA− gut
microbiota, and their cultivation to support subsequent
interrogation in gnotobiotic disease models and/or strain
phenotyping. Our FACS-based protocol outperformed
MACS in sort purity and benefits from innate quantifi-
cation of the IgA+ and IgA− fraction sizes required to
calculate the probability ratio. We employed a protocol
design strategy that combined individual approaches ap-
plied in previous studies including the controls used for
validation of the staining and gating strategy [17, 18].
Whilst access to specific flow cytometers may vary, the
concepts in experimental design presented herein can be
applied to validate IgA-Seq protocols on different sort
modalities. To minimize technical variation between ex-
periments, regular instrument calibration alongside
staining controls and gating templates should be
employed.
This framework can additionally be used to evaluate
reagent selection, a process essential to obtaining robust
IgA-Seq results. To differentiate bacteria from intestinal
debris, we utilised a sensitive SYBR I dye that efficiently
stains diverse bacteria and has been used in other IgA-
Seq studies [30, 31], whilst others have used SYTO BC
dyes [12, 18, 20]. More comprehensive studies are
needed to elucidate the potential for taxon-specific false
positives and negatives that occur with the usage of dif-
ferent DNA dyes in different environmental contexts.
We selected anti-mouse IgA antibody clone mA-6E1 for
our studies, which has been used by Palm et. al., Huus
et. al. and a large number of other IgA-Seq studies [6,
29, 37–40]. We utilised the same antibody lot for all
experiments within this study, but staining controls
and gating strategies need to be verified in instances
of lot-to-lot variation. Other studies have also used
polyclonal antibodies and biotin-streptavidin staining
approaches [12, 18]; future work applying similar
benchmarks will help shed light on how these may
differ in specificity and/or affinity and the subsequent
impact on IgA-Seq results. The use of germ-free and
Rag1−/− mice as negative controls and our novel posi-
tive control approach to protocol evaluation, isolating
pure IgA-bound B. theta from a complex microbiota,
provide benchmarking standards to validate these
various reagents in the context of specific experimen-
tal setups.
16S rRNA gene sequencing has enhanced our ability
to identify microbes in a variety of environments, includ-
ing low biomass samples for IgA-Seq. A major challenge
to accurately characterize low biomass communities is
contamination from external sources, as we observed in
the enrichment of low abundance contaminant reads in
our sorted samples. Contamination could potentially
occur during sorting, DNA extraction and library prep-
aration [41]. Whilst our negative FACS sheath controls
were blank, environmental contamination could still
occur whilst sorting IgA+ and IgA− fractions as sample
and collection tubes remain open for the duration of the
sort. In our in vivo model, using a library prepared from
a blank kit, we were able to trace some but not all con-
taminants to the DNA extraction step, a well-established
source of contaminants [41]. In addition, index hopping
and stochastic sequencing effects have been shown to
contribute to noise in low biomass samples on the Illu-
mina MiSeq platform [42, 43]. In our study, even utilis-
ing a defined MM12 community along with the
inclusion of sheath and extraction controls, there were
inevitably low abundance contaminants that needed
screening from the sorted fractions. This highlights the
need to carryout rigorous controls for the low biomass
sequencing runs. In particular, we found it invaluable
having the pre-sort sample sequencing available as a ref-
erence to remove taxa not observed in this higher bio-
mass source.
Similar approaches to IgA-Seq have also been used to
study other isotypes, such as IgM and IgG [22, 44–46],
and immunoglobulins isolated from other sites, for ex-
ample quantifying GI bacteria bound by serum IgA [29].
Expanding beyond IgA targeting of the gut microbiota,
in future work, our protocol design strategy and scoring
approaches could be applied to investigate other sample
types and immunoglobulins. Further work could also be
done to explore other sequencing variables influencing
IgA binding scores. For example, amplicon-based taxo-
nomic abundances are inherently influenced by PCR
biases, differences in 16S rRNA gene copy number and
the taxonomic resolution of the variable region amplified
[47–49]. However, these are more general limitations of
16S rRNA gene sequencing and their impact should be
minimised assuming they occur uniformly in the IgA+
and IgA− fraction. Mock sorts have previously shown
that the sorting process itself has little influence on com-
munity structure [17].
Technical variation in the isolation of IgA+ bacteria
will also influence IgA binding estimates. We have not
explored the influence of sort purity on binding esti-
mates. We assume that using a less pure sorting ap-
proach such as MACS would reduce the accuracy of IgA
binding indices across the various scoring approaches.
This is not likely to influence study outcomes if sort
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purity is uniform across an experiment but it may be
valuable to ensure that this is the case; in particular to
check that sort purity is not correlated with experimen-
tal conditions. Similarly, using a more sensitive anti-IgA
antibody or setting wider IgA+ gating in FACS will in-
crease the size of the IgA+ fraction and inherently in-
crease the likelihood a taxon will be IgA+. This will not
influence relative scoring between taxa within a sample
but it is important to maintain these variables across
samples in an experiment and/or consider randomisa-
tion of samples across technical batches to avoid con-
founding of experimental groups. For similar reasons,
absolute score values from any method are unlikely to
be analogous between experiments; however, the relative
rankings of taxa should remain comparable. IgA-Seq is
additionally limited to scoring relative, overall, IgA bind-
ing between taxa. Understanding what drives the ob-
served differences, such as alterations in the spatial
distribution of bacteria or changes in the affinities of
host IgA, requires additional targeted experiments, such
as fluorescence in situ hybridisation and enzyme-linked
immunosorbent assays [10, 20].
We have developed an optimised experimental proto-
col and novel scoring methodologies for IgA-Seq. These
enable robust and accurate identification of commensal
bacteria targeted by the host immune response. The
IgAScores R package facilitates the application of these
scores and we have presented a guiding framework for
selecting appropriate metrics. Furthermore, its simula-
tion platform will aid the future development of IgA-Seq
analytics. This work enhances the accessibility and qual-
ity of IgA-Seq studies, which should consequently un-
cover novel mechanistic insights into host-microbiota
interactions and the microbial drivers of health and
disease.
Conclusion
Existing methods used to score taxon-level IgA binding
in IgA-Seq experiments are influenced by the initial
taxonomic composition of samples and the relative na-
ture of abundance quantification. This inflates the vari-
ability in these scores and can have important
consequences in between-group comparisons, where
scores might infer false or contrasting associations as a
result of systematic differences in microbiome compos-
ition between groups. Probability-based IgA scores can
be used that overcome this by providing a direct esti-
mate of the likelihood a bacterium will be bound by IgA
given its taxonomy. These scoring methods are available
in the IgAScores R package. Combined with the practical
approaches described here, these analytical develop-
ments enhance our ability to study taxon-level immuno-
globin binding of commensal microbiota; by increasing
the power to detect associations through reduced
variability across samples and by providing an accurate,
direct, quantification of taxon binding from IgA-Seq
data.
Methods
Indices for scoring relative IgA binding of taxa in IgA-Seq
experiments
Palm index
In Palm et al.’s initial description of IgA-Seq, they simply
used the ratio of a taxon’s IgA+ to IgA− abundance in a
score termed the IgA coating index [17]. Here, for clar-
ity, we refer to this as the Palm index (Palm). If IgA+
and IgA− represent taxon abundances in the respective
fractions, for taxon i in sample j the Palm index is de-
fined as in Eq. 1, where if IgA −ij is equal to zero a
pseudo count (c) is added to negate division by zero.
Throughout, we use a pseudo count of a similar magni-







Kau et al. described the IgA index, which is also solely
based on IgA+ and IgA− relative abundances [18]. It uses
log transformation to make scores more comparable be-
tween taxa and considers the difference of the IgA+ and
IgA− abundances relative to their total. This has the
benefit of centering the score such that positive and
negative values reflect overall higher abundances in the
IgA+ or IgA− fractions respectively. Using notation as
previously, the Kau index (Kau) is defined as in Eq. 2.
Kauij ¼ −
log IgAþij þ c
 
− log IgA −ij þ c
 
log IgAþij þ c
 
þ log IgA −ij þ c
  ð2Þ
IgA+ probability
The relative abundances of taxa in a fraction or pre-sort
sample sum to one. These can be considered as prob-
abilities. For example, taxa abundances in the pre-sort
sample represent the probability that any given bacter-
ium in the sample belongs to a given taxon. The abun-
dances in the IgA+ and IgA− fractions can be considered
as conditional probabilities (i.e. the probability of event
A given that B has occurred). For instance, IgA+ abun-
dances represent the probability a bacterium belongs to
a taxon given that it is sufficiently bound to IgA to be in
the IgA+ gate. In the case of IgA-Seq, we are interested
in the inverse: the probability that a bacterium will be
IgA+ if it belongs to a given taxon. This is a posterior
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probability and can be calculated following Bayes’ the-
orem (Eq. 3).
P AjBð Þ ¼ P BjAð ÞP Að Þ
P Bð Þ ð3Þ
Where P(A| B) is the posterior probability that a bac-
teria is IgA+ given that it is from a chosen taxon. P(A) is
the probability that any bacterium is bound to IgA suffi-
ciently to be in the IgA+ fraction—measured as the per-
centage of bacteria that fall within IgA+ FACs gate. P(B)
is the probability that a bacterium will belong to a given
taxon—measured as the taxon’s relative abundance in
the pre-sorted sample. P(B|A) is the probability a bac-
teria belongs to the taxon given that it is in the IgA+
fraction—measured by the taxon’s IgA+ abundance. In
which case, the posterior probability (ProbIgA
þ
) for taxon
i in sample j is defined as in Eq. 4.1. Where FracSize
equals the fraction of sorted bacteria in the IgA+ gate










This measure will be referred to as the IgA+ probabil-
ity. The numerator provides a direct estimate of the pro-
portion of initial bacteria bound to IgA avoiding the
relative influence of other taxa in the IgA+ fraction
abundance. The numerator must be normalised to the
total amount of that taxon in the original sample prior
to sorting (PreSort) to make it comparable across taxa.
As this is the pre-sort level of the taxon, the denomin-
ator should theoretically always be larger or equal in
value. However, due to amplification and other technical
biases, this may not practically be the case in IgA-Seq
data, thus Eq. 4.2 can be used to account for this and en-












This will assign a probability of 1 when the estimate of
IgA+ bacteria in a taxon is larger than the observed total
abundance in the pre-sort sample, a reasonable assump-
tion being that very high levels of IgA binding would be
necessary to produce these results.
This score only requires two additional pieces of data
than the Kau and Palm indices: the taxonomic abun-
dances in the pre-sort fraction and the percentage of
sorted bacteria that are in the IgA+ gate in the FACS
run. The latter value is already generally recorded during
sorting and most IgA-Seq studies to date have profiled
the microbial communities from pre-sorted sample s[17,
18]. Furthermore, if the only interest is to identify highly
bound taxa, this method can negate the need to se-
quence the IgA− fraction.
Probability ratio
The IgA+ probability only provides a measure of the
likelihood a taxon is sufficiently bound to IgA to be in
the IgA+ fraction. The converse, the IgA− probability,
can also be calculated by simply substituting the IgA−
abundances and fraction sizes into the IgA+ probabil-
ity equation. The IgA− probability thus represents the
probability a bacterium is in the IgA− fraction given
it belongs to a given taxon. If we calculate both the
IgA+ and IgA− probabilities from a sample, we can be
combine the estimates by comparing the ratio of the
IgA+ probability to IgA− probability, a score we term
the IgA probability ratio (Eq. 5). This provides finer
granularity of estimates of the relative binding be-
tween taxa with low levels of IgA binding than using
the IgA+ probability alone. Additionally, as both the
IgA+ and IgA− probabilities are normalised to the tax-
on’s abundance in the pre-sort fraction, this can be
removed from the equation (Eq. 5) negating the need
to sequence the pre-sort sample whilst still account-

















Pseudo counts (c) must be included in the probability
ratio to negate division by zero where taxa are not ob-
served in the IgA− fraction. Using the probability ratio
has the benefit of capturing both extremes of IgA bind-
ing within a single score (whereas the IgA+ or IgA−
probabilities are limited to either direction). Addition-
ally, we take the log of the ratio, which, similar to the
Kau index, centres values on zero. This directionality
provides a clear indication of whether bacteria in a taxon
have a higher probability of being found in the IgA+ or
IgA− fractions.
One limit of using the ratio as in Eq. 5 is that the
range of possible values returned is determined by the
pseudo count used. The magnitude of these effects can
be reduced by dividing ProbRatio by a scaler based on
the pseudo count as in Eq. 6. This will bring all values
within the range − 1 to 1, with these values representing
the extreme case where all bacteria are in a single
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fraction and belong to a single taxon. Scaled probability
ratios are used throughout.




The Palm, Kau, IgA+ probability and probability ratio
scores were all calculated as defined above using the iga-
scores function that we have created as part of an R
package IgAScores, which is available at https://github.
com/microbialman/IgAScores.
Simulating an IgA-Seq experiment
A simulation was used to generate IgA-Seq data where
the underlying relative taxonomic binding of IgA bind-
ing was known. Ten species were assigned a mean IgA
binding value by random sampling from an exponential
distribution (raising two to the power of the generated
values to increase their spread). These values are arbi-
trary numbers that simply provide a relative IgA binding
measure between the species and are used as the mean
to generate a normal distribution of IgA binding for
each species (with a standard deviation of one). For ini-
tial simulations, 30 samples were then generated with
random pre-sort abundances for the ten species sampled
from a log normal distribution.
To simulate an IgA-Seq experiment, each sample was
assumed to have profiled 100,000 bacteria (a reasonable
magnitude for 16S rRNA gene sequencing). For each
sample, the 100,000 counts were assigned to one of the
ten species based on the sample’s species abundances.
Then, for each of the 100,000 bacteria in each sample, a
value of IgA binding was generated at random from the
normal distribution defined by its species mean. The dis-
tribution of IgA scores across all species was used to
identify values that cut off the upper and lower tails of
IgA binding and these were used to define the bacteria
within the IgA+ and IgA− fractions respectively. The bac-
teria within the IgA+ and IgA− fractions for each sample
were then used to generate the IgA+ and IgA− relative
abundances and all other measures required for generat-
ing the various IgA-Seq scores.
A secondary simulation was performed to model the
case where two groups are compared with a consistent
difference in starting abundances between them. For
this, the simulation was run using the same ten species
as before but now considering 60 samples. Additionally,
prior to generating bacterial IgA binding values, 0.5 was
added to the abundance of species ten in half of the
samples before renormalizing the abundances to sum to
one. Samples with additional species ten were consid-
ered cases and the unaltered samples considered
controls.
All stages of the IgA-Seq simulation were carried out
using the function simulateigaseq, which is also part of
the IgAScores package. All IgA-Seq indices were calcu-
lated as defined previously using the igascores function.
For simulated data experiments, a value of 10−6 was used
for pseudo counts when required as this was the same
magnitude as the minimum non-zero abundance value
observed in the simulated data. Correlations were
assessed using the cor function in R [50]. Between group
comparisons were performed using the wilcox.test func-
tion, adjusting p values using p.adjust. Code for all simu-
lation analyses can be found at https://github.com/
microbialman/IgAScoresAnalyses.
Bacterial culture
Bacteroides thetaiotaomicron VPI-5482 (B. theta) was
cultured at 37 °C in in brain heart infusion broth supple-
mented with 5 μg/ml hemin and 0.5 μg/ml vitamin K
(BHIS medium) under anaerobic conditions (10% H2,
10% CO2, 80% N2). Escherichia coli LF82 was cultured
aerobically at 37 °C in Luria-Bertani (LB) medium. Heli-
cobacter hepaticus ATCC 51449 was grown in tryptone
soya broth (TSB) supplemented with 10% fetal calf
serum and Skirrow Campylobacter supplements (Oxoid)
under microaerophilic conditions (1–3% oxygen). To
stain bacteria, pure overnight cultures were pelleted by
centrifugation (8000×g, 5 min, 4 °C), washed in sterile
phosphate-buffered saline (PBS) and blocked with filter-
sterilized 10% mouse serum (10 min, ice). The following
monoclonal antibodies were used to stain bacteria in a
100 μl volume: mouse IgG2b anti-E. coli (1:100; Abcam
clone 2D7/1) and mouse IgA anti-B. theta (1:100; clone
255.4 [32]). To generate the 2-member community, the
optical density (OD, 600 nm) and corresponding colony-
forming units (CFU) were determined for OD600 of 1: E.
coli 8 × 107 CFU; B. theta 1.2 × 108 CFU. Acutalibacter
muris KB18, Akkermansia muciniphila YL44, Bacter-
oides caecimuris I48, Bifidobacterium animalis subsp.
animalis YL2, Blautia coccoides YL58, Clostridium clos-
tridioforme YL32, Clostridium innocuum I46, Entero-
coccus faecalis KB1, Flavonifractor plautii YL31,
Lactobacillus I49, Muribaculum intestinale YL27 and
Turicimonas muris YL45 were used to generate stably
colonized MM12 mice [51].
Mouse strains
All experiments were conducted in accordance with the
UK Scientific Procedures Act (1986) under a Project Li-
cense (PPL) authorized by the UK Home Office. Animals
were housed in accredited animal facilities at the Univer-
sity of Oxford and provided with sterile water, food ad
libitum and environmental enrichment. Both males and
females were used in experiments after 8 weeks of age.
Specific pathogen-free (SPF) C57BL/6J and C57BL/6J
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Rag1−/− mice were routinely tested and negative for
Helicobacter spp. and other known intestinal pathogens.
Germ-free (GF) C57BL/6J mice were maintained in ster-
ile flexible film isolators and routinely screened for bac-
terial contamination by culturing, Gram stain and 16S
rRNA gene PCR. GF C57BL/6J mice were stably colo-
nized with a defined consortium of 12 bacterial mem-
bers, see below, of murine intestinal microbiota to
generate a sDMDMm2 [35, 51] (MM12) colony that was
maintained in sterile flexible film isolators. All GF and
MM12 mice were maintained on sterile food and water.
Helicobacter hepaticus-induced colitis
To induce colitis using Helicobacter hepaticus (Hh),
NCI-Frederick isolate 1A strain 51449 was grown as pre-
viously described [52]. Littermate control mice with
MM12 microbiota were randomly assigned to groups.
Mice were fed 1.0 × 108 CFU by oral gavage on day 0
and 1. On day 0 and 7, 1 mg IL-10 receptor blocking
antibody (clone 1B1.2) was delivered by intraperitoneal
injection. Control mice were housed in a separate flex-
ible film sterile isolator and were given IL-10 receptor
blocking antibody in the absence of Hh administration.
Animals were routinely monitored for weight loss and
onset of diarrhoea. Mice were sacrificed at day 14 and
processed aseptically in a class II microbiological safety
cabinet. Colon contents were collected for IgA-Seq and
lipocalin-2 measurements (EMLCN2, Life Technologies)
and stored at − 80 °C. Formalin-fixed paraffin-embedded
cross-sections of proximal, middle and distal colon were
stained with haematoxylin and eosin to assess histopath-
ology. Sections were examined for hallmarks of inflam-
mation: epithelial hyperplasia, goblet cell depletion,
leukocyte infiltration, crypt abscess formation, submuco-
sal leukocyte infiltration and interstitial edema.
Lipocalin-2 enzyme-linked immunosorbent assay
To prepare intestinal supernatants, 50–100 mg of colon
contents were added to screw-capped O-ring tubes filled
with 1 ml of cOmplete ULTRA EDTA-free protease in-
hibitor (Roche). Samples were homogenized on the Tis-
sueLyser II (QIAGEN) for 10 min at 30 Hz and debris
separated by centrifugation (10,000×g for 5 min at 4 °C).
Supernatant was carefully collected and either used im-
mediately or stored at − 20 °C. Lipocalin-2 was quanti-
fied using a mouse LCN2 enzyme-linked
immunosorbent assay (ELISA) kit (ThermoScientific) ac-
cording to manufacturer’s instructions. Each sample was
run in duplicate and measurements reported as ng of
lipocalin per gram of sample.
Preparation of samples for bacterial flow cytometry
Only sterile reagents were used to process samples. Fro-
zen stool and intestinal contents (10–50 mg of sample)
were rehydrated in 1 ml of PBS and suspended by vor-
texing. Large debris were separated by centrifugation
(50×g, 15 min, 4 °C) and the clarified supernatant was
passed through a 70 μm filter. A 500 μl aliquot of the
suspension was transferred into a new 1.5 ml microcen-
trifuge tube and an additional 1 ml of PBS added. Bac-
teria were pelleted (8000×g, 5 min, 4 °C) and blocked
with 100 μl of 10% rat serum (10 min, ice). An add-
itional 1 ml of PBS was added to the blocking suspen-
sion and centrifuged, and pelleted bacteria were washed
with 1 ml of FACS buffer (PBS + 1% bovine serum albu-
min). Following centrifugation, the resulting pellet was
stained with PE-conjugated rat anti-mouse IgA (1:100,
eBioscience clone mA-6E1) in a 100 μl volume (30 min,
covered on ice). Clone mA-6E1 was titrated testing con-
centrations of 1:10, 1:20, 1:50, 1:100, 1:200, 1:500 and 1:
1000. Samples were washed twice with FACS buffer and
resuspended in 1 ml buffer containing SYBR Green I nu-
cleic acid gel stain (1:400,000, Life Technologies) in the
dark at room temperature. The optimal concentration of
SYBR was determined by titration testing a range from
1:100,000 to 1:500,000. Samples were then placed in a
covered ice box and immediately acquired on the flow
cytometer (LSRFortessa X20 and FACSAria III, BD
Biosciences).
To validate the IgA-Seq protocol, 1 ml of an overnight
B. theta culture was first stained with mouse IgA clone
255.4 (25 min, ice), washed with 1 ml PBS, followed by
staining with PE-conjugated rat anti-mouse IgA (1:100,
eBioscience clone mA-6E1). Stained bacteria were
washed three times in FACS buffer before resuspension
in 1 ml FACS buffer. A 500 μl aliquot of IgA-coated B.
theta was spiked into a faecal suspension prepared from
specific pathogen-free (SPF) C57BL/6J mice. SYBR was
added to the final mixture.
Fluorescence-activated cell sorting of bacterial
populations
Samples were sorted using a FACSAria III (BD Biosci-
ences) instrument with external aerosol management.
Both sample and collection tubes were maintained at 4
°C. Sterile, preservative-free PBS without calcium or
magnesium (Invitrogen) was used for sheath fluid and
was autoclaved prior to sorting. The flow cytometer was
sterilized according to the manufacturer’s Aseptic Sort
protocol to decontaminate the entire sheath and sample
paths. In addition, both before and after sorting, freshly
made 10% bleach was run for 20 min on max flow rate
followed by sterile PBS for 10 min. Sheath fluid from the
droplet stream was collected prior to sorting as a con-
trol. Sample Line Backflush was run between samples to
prevent carryover.
For finer resolution of small particles including bac-
teria, the neutral density filter was removed and
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threshold set to 200 for side scatter (SSC). Drop delay
values were determined with the Accudrop feature and
were updated with each new sort setup. To sort and cul-
ture live B. theta, various nozzle sizes (70, 85, 100 μm)
and sheath pressures (20, 30, 45, 70 psi) were tested. A
10 × 10 grid was programmed into the automated cell
deposition unit (ACDU) stage, and B. theta suspended
in PBS was sorted in Single Cell precision mode onto
BHIS agar plates for enumeration of colony-forming
units (CFU). Nozzle sizes and sheath pressures were also
tested for sort purity of IgA+ and IgA− populations of
faecal bacteria.
For stool and intestinal samples, the SYBR nucleic acid
stain (FITC channel) helped to differentiate bacteria
from autofluorescent debris (BV421 or PerCP Cy5.5
channels). Samples were diluted in fluorescence-
activated cell sorting (FACS) buffer containing SYBR in
order to achieve an event rate of 5000–6000 events per
second. To begin, 100,000 events were recorded from
the initial sample (pre-sort) in order to calculate the per-
centage of bacteria in the IgA+ and IgA− gates used in
the probability-based scores. Gates were then drawn to
delineate bacterial populations that were bound with
IgA (IgA+) or unbound (IgA−). The 4-way purity preci-
sion mode was used to capture 400,000 events for each
IgA+ or IgA− fraction. Fractions were collected into
autoclaved 2 ml screw cap tubes (ThermoFisher Scien-
tific) pre-coated with 200 μl FACS buffer. Sort purity of
each fraction was recorded from 100 events, and DNA
was immediately extracted from the remainder. BD
FACSDiva and Flowjo software (TreeStar) were used for
instrument setup and data analysis.
Magnetic-activated cell separation
As a comparison with FACS, IgA-stained samples were
incubated for 30 min at 4 °C with anti-PE microbeads
(1:50, Miltenyi) in magnetic-activated cell separation
(MACS) buffer (0.5% bovine serum albumin and 2 mM
EDTA in PBS). Microbeads were titrated by testing con-
centrations of 1:5, 1:20, 1:50, 1:100, 1:200, 1:500. Cells
were pelleted by centrifugation (10,000×g, 5 min, 4 °C)
and washed twice in MACS buffer before resuspension
in 1 ml. LS columns (Miltenyi) were placed on a mag-
netic stand (Miltenyi) and pre-washed with 10 ml MACS
buffer before the sample was loaded. Unlabelled “MACS
neg” cells were collected in 3 × 3 ml washes. The LS col-
umn was then removed from the magnet and the la-
belled “MACS pos” cells were collected in 6 ml MACS
buffer using the LS column plunger. MACS fractions
were then analysed for purity by flow cytometry.
DNA extraction
Only sterile molecular-grade reagents and filter-
sterilized buffers were used to extract DNA. Sorted
fractions were centrifuged (16,000 × g, 20 min, 4 °C) and
the supernatant removed such that only 300 μl remained
in the tube. For unsorted (pre-sort) samples, 100 μl was
transferred into an autoclaved 2 ml screw cap tube con-
taining 200 μl FACS buffer. The following was then
added to each tube: 250 μl autoclaved 0.1 mm zirconia/
silica beads (Biospec), 300 μl Lysis buffer (200 mM NaCl;
200 mM Tris; 20 mM EDTA; pH 8), 200 μl 20% SDS
and 500 μl of phenol:chloroform:isoamylalcohol (PCI 25:
24:1, pH 7.9, Sigma). Samples were bead beaten (6500
rpm for 4 min, 3 min on ice, repeat 2×, Precellys tissue
homogeniser), then centrifuged (6000×g, 10 min, 4 °C)
to separate phases. The aqueous phase was transferred
into 5PRIME Phase Lock Gel Light tubes (Quantabio)
and an equal volume of PCI added. After mixing by in-
version, samples were centrifuged (16,000×g, 10 min)
and the aqueous phase transferred to a new Eppendorf
tube. DNA was precipitated with 1/10 volume 3 M
NaOAc (pH 5.5) and 1 volume of isopropanol overnight
at − 20 °C. After precipitation, DNA was pelleted (16,
000×g, 30 min, 4 °C) and the supernatant carefully re-
moved. The pellet was washed in 500 μl 70% ethanol,
centrifuged (16,000×g, 10 min, 4 °C) and the wash re-
peated again. Residual ethanol was removed from pel-
leted DNA and the tube placed on a 37 °C heat block
until the pellet was completely dry. Cleaned DNA pellets
were resuspended in 30 μl TE buffer at 50 °C for 30
min, then stored at − 20 °C until 16S rRNA gene library
preparation.
16S rRNA gene sequencing
The V4 region of 16S ribosomal RNA gene was ampli-
fied using barcoded primer pairs [53, 54]. Amplicons
were generated in 50 μl PCR reactions: template DNA (2
μl), 10 μM 515F primer (1 μl), 10 μM 806R (1 μl),
5PRIME HotMasterMix (20 μl) and water (26 μl). Water
was added instead of DNA for no-template controls.
Thermocycler conditions: 94 °C for 3 min; 35 cycles of
94 °C for 45 s, 50 °C for 60 s and 72 °C for 90 s; 72 °C
for 10 min. Amplicons were cleaned (UltraClean PCR
Clean-Up Kit, QIAGEN) and quantified (Quant-iT
dsDNA high-sensitivity kit, ThermoFisher) in triplicate
before pooling. The pooled library was precipitated with
2 volumes of 100% ethanol and a final concentration of
0.2 M NaCl (45 min, ice). The supernatant was removed
following centrifugation (7800×g, 40 min, 4 °C) and the
pellet washed with 1 volume of 70% ethanol. The
cleaned library was pelleted (7800×g, 20 min, 4 °C) and
air dried to remove residual ethanol before resuspending
in 100 μl DNAase-free water. Gel clean-up was per-
formed (QIAquick Gel Extraction Kit, QIAGEN) and the
final library was sequenced on the MiSeq (Illumina) plat-
form to generate 2 × 250 base pair paired-end reads.
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All 16S rRNA gene sequencing data were quality
checked using FastQC and processed using DADA2
within the NGSKit pipeline (https://github.com/
nickilott/NGSKit) to generate an amplicon sequence
variant (ASV) table [55]. In brief, DADA2 was run on
each sample individually. The filterAndTrim function
was first used on the paired-end files with the following
parameters: trunclen 240,140; maxN 0; maxEE 2,2;
truncQ 2. These filtered forward and reverse read files
were then used for generation of the error models using
the learnErrors function over 10,000,000 bases; for dere-
plication using the derepFastq function; and for sample
inference using the dada function. The reads were then
merged using mergePairs and chimeric reads screened
using removeBimeraDenovo. The assignTaxonomy and
addSpecies functions were used to assigned taxonomy to
ASVs using a database built from a combination of both
the RefSeq and RDP databases [56]. Unless otherwise
specified, the default parameters were used for all func-
tions. ASV counts were then summarised at the species
level and all analyses carried out on these relative abun-
dances (summing to one within a sample).
IgA-Seq in a mouse model of colitis
ASV counts were generated from 16S rRNA gene se-
quences as described above, producing 54,091 ± 7970
(mean ± SD) ASV counts per sample (excluding the
blank control which had 5119 counts). These were sum-
marised at the species level. Given the samples con-
tained a known MM12 microbiota, the presence of
unexpected species in samples and species observed in a
sequencing control blank were used to find an abun-
dance threshold that removed the majority of contami-
nants. Non-metric multi-dimensional scaling was used
to visualise the relationship between samples from each
mouse in each fraction using the metaMDS function
from the vegan R package [57]. Comparisons of IgA-Seq
data were performed between the four anti-IL10R only
controls and the four Hh-treated mice for the Palm, Kau
and the probability ratio scores. These were generated
using the igascores function as for the simulated data. A
pseudo count of 10−3 was added where necessary as this
was the magnitude of the lowest non-zero abundance
value observed in the data.
Scores were compared between the colitic and control
groups for taxa where there were at least three samples
scored in both groups (taxa were scored NA if they had
zero abundance in both the positive and negative frac-
tions). Given the small sample size of each comparison,
significant differences were determined by carrying out
all possible permutations of group labels and observing
the difference in group means for each taxon for each
score. The true difference in means was compared to
the differences across permutations to derive an exact p-
value, considering significance where p < 0.1. This more
permissive threshold was used given the small sample
size (min three per group). To generate comparable ef-
fect sizes between scores, which are on different scales,
the difference in means between groups was normalised
to the standard deviations within the groups using the
strictly standardised mean difference, calculated using
the ssmd function from the phenoDist R package [58].
The species level data for these analyses are made avail-
able within the IgAScores package and all code for the
ana l y se s a re ava i l ab l e a t h t tps : / / g i thub . com/
microbialman/IgAScoresAnalyses.
Analysis of Huus et al.’s data
Sample metadata, IgA+ and IgA− fraction sizes and the
pre-processed taxon count table used in the original
study were provided by the authors. The counts table
was filtered to remove low abundance taxa using code
published with the original study and then subset to just
the samples for which the fraction sizes were available.
The Kau Index and probability ratio scores were then
generated using the igascores function as previously. For
each taxon, a two-way analysis of variance (ANOVA)
was performed, using the aov function in R, to deter-
mine if there was a difference in IgA binding score be-
tween diet treatments or the interaction of diet and
mouse age. This was carried out for both the Kau Index
and probability ratio, considering a taxon significant if
either diet or the diet-age interaction had a nominal p <
0.05. Taxa were only tested that had scores (i.e. were not
absent in both the IgA+ and IgA− fractions) in at least
six samples spread across all age points and both condi-
tions. The magnitude of effects was estimated as the dif-
ference in mean scores between MAL and CON for each
taxon and was calculated at each of the three ages indi-
vidually. Mean differences were normalised by the stand-
ard deviation within groups, using the strictly
standardised mean difference as for the colitis analysis
(to make the values comparable between the Kau index
and probability ratio). Coefficient of variation was calcu-
lated within each taxon within each experimental group
(age and diet combined) for each scoring method and
compared using a Mann-Whitney test. All code for the
replication analysis can be found at https://github.com/
microbialman/IgAScoresAnalyses.
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